Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Manning

Showing results (581-590 of 821) with videos related to

Pageof 83
Sort By:
Journal of Agricultural and Food Chemistry|July 11, 2000
Use of phosphonic acid as a generic hapten in the production of broad specificity anti-organophosphate pesticide antibodyM J Alcocer, P P Dillon, B M Manning, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Advances in the design of selective antagonists, potential tocolytics, and radioiodinated ligands for oxytocin receptorsM Manning, L L Cheng, W A Klis, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 18, 2023
Osteoporosis and fracture as risk factors for self-harm and suicide: a systematic review and meta-analysisFay M Manning, Faraz Mughal, Hazem Ahmed Saad Mohamed Ismail, et al.
Cells|September 8, 2023
Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on SialylationChristopher Beneduce, Stephanie Nguyen, Nathaniel Washburn, et al.
Journal of Medicinal Chemistry|December 1, 1987
C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptorsM Manning, A Misicka, A Olma, et al.
The EMBO Journal|May 15, 1995
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptorB Chini, B Mouillac, Y Ala, et al.
Clinical and Experimental Hypertension|January 1, 1981
Vasopressin in the rat with partial nephrectomy-salt hypertensionW J Lee-Kwon, L Share, J T Crofton, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 1, 1997
Position three in vasopressin antagonist tolerates conformationally restricted and aromatic amino acid substitutions: a striking contrast with vasopressin agonistsM Manning, L L Cheng, S Stoev, et al.
The Journal of Biological Chemistry|December 25, 1993
Biochemical and functional properties of recombinant human sickle hemoglobin expressed in yeastJ J Martin de Llano, W Jones, K Schneider, et al.
The EMBO Journal|November 14, 1997
Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligaseA Yaron, H Gonen, I Alkalay, et al.
Pageof 83

Showing results (581-590 of 821) with videos related to

Sort By:
Pageof 83
Journal of Agricultural and Food Chemistry|July 11, 2000
Use of phosphonic acid as a generic hapten in the production of broad specificity anti-organophosphate pesticide antibodyM J Alcocer, P P Dillon, B M Manning, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Advances in the design of selective antagonists, potential tocolytics, and radioiodinated ligands for oxytocin receptorsM Manning, L L Cheng, W A Klis, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 18, 2023
Osteoporosis and fracture as risk factors for self-harm and suicide: a systematic review and meta-analysisFay M Manning, Faraz Mughal, Hazem Ahmed Saad Mohamed Ismail, et al.
Cells|September 8, 2023
Inhibitory Fc-Gamma IIb Receptor Signaling Induced by Multivalent IgG-Fc Is Dependent on SialylationChristopher Beneduce, Stephanie Nguyen, Nathaniel Washburn, et al.
Journal of Medicinal Chemistry|December 1, 1987
C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptorsM Manning, A Misicka, A Olma, et al.
The EMBO Journal|May 15, 1995
Tyr115 is the key residue for determining agonist selectivity in the V1a vasopressin receptorB Chini, B Mouillac, Y Ala, et al.
Clinical and Experimental Hypertension|January 1, 1981
Vasopressin in the rat with partial nephrectomy-salt hypertensionW J Lee-Kwon, L Share, J T Crofton, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|January 1, 1997
Position three in vasopressin antagonist tolerates conformationally restricted and aromatic amino acid substitutions: a striking contrast with vasopressin agonistsM Manning, L L Cheng, S Stoev, et al.
The Journal of Biological Chemistry|December 25, 1993
Biochemical and functional properties of recombinant human sickle hemoglobin expressed in yeastJ J Martin de Llano, W Jones, K Schneider, et al.
The EMBO Journal|November 14, 1997
Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligaseA Yaron, H Gonen, I Alkalay, et al.
Pageof 83